Top Syringe Brands: Unveiling Excellence in Precision and Safety

When it comes to choosing high-quality syringes, selecting the right brand can make a significant difference in ensuring precision and safety. With an array of manufacturers in the market, healthcare professionals often look for trusted names that guarantee sterility and reliability. Factors such as needle sharpness, ease of use, and robustness play a crucial role in determining the top-performing brands in the industry. To help guide your selection, we have compiled a comprehensive list of the best brands for syringes below.

Illustration of syringes

Best brands of syringes in 2025

BD

BD (Becton, Dickinson and Company) is a leading global medical technology company, renowned for its high-quality syringes and commitment to patient care. With over 125 years of history, BD has manufactured 2 billion additional syringes and needles to support the global pandemic response to COVID-19. The company has increased domestic production in its Nebraska and Connecticut facilities to meet U.S. healthcare needs, particularly in response to recent FDA safety communications. BD is the only major manufacturer of hypodermic syringes supporting the U.S. market that manufactures primarily in the U.S., employing 1,600 U.S.-based manufacturing employees. Its products, such as the BD Luer-Lok(tm) Syringe, are the world's No. 1 selling syringes.

Terumo Corporation

Terumo Corporation is a leading producer of syringes, renowned for its advanced manufacturing technology and commitment to quality. The company is expanding its production capacity, with a planned increase of 3.5 times by 2023 compared to 2016, through a JPY 15 billion investment in new facilities at Terumo Yamaguchi D&D Corporation. Terumo's Alliance Division, engaged in the contract development and manufacturing organization (CDMO) business, saw a 16% year-on-year growth in revenue to JPY 23.6 billion by March 2020. The company is also a major player in the global pre-filled syringes market, which is expected to grow significantly, reaching $10.46 billion by 2026 at a CAGR of 13.2%. Terumo's innovative products, such as the Nanopass series, aim to reduce pain and fear associated with injections, particularly for diabetes patients. For more detailed insights about their products and innovations, visit their official website: Terumo Corporation's website.

Nipro Corporation

Nipro Corporation is a leading global manufacturer of high-quality medical devices, particularly renowned for its syringe production. The company has seen significant growth, with net sales increasing by 8.6% in the fiscal year ended March 2022, driven by increased demand for anti-infection products and vaccination-related items. Nipro is expanding its syringe production lines in Germany and is set to establish its first North American manufacturing center in Greenville, North Carolina, investing over $397.8 million and creating 232 jobs. The company's commitment to innovation and patient care is evident in its diverse product range, including dialyzers, insulin needles, and other medical devices. Nipro's global presence and continuous investment in production facilities ensure a stable supply chain and reduced transportation costs.

Smiths Medical

Smiths Medical, now a part of ICU Medical, is a renowned producer of syringes and other medical devices, known for its high-quality syringe and ambulatory infusion devices, vascular access, and vital care products. The acquisition by ICU Medical in 2022 expanded their global reach, creating a leading infusion therapy company with estimated pro forma combined revenues of approximately $2.5 billion. Smiths Medical's products are integral in reducing infection risks and enhancing patient care, particularly with the increasing adoption of safety syringes, which dominated the U.S. disposable syringes market with a 64.5% share in 2023. Their innovative solutions are crucial in managing chronic and infectious diseases, contributing to the significant growth in the syringes market. The integration has enhanced the stability of the medical supply chain and positioned the company for continued growth as clinical care models evolve.

B. Braun Melsungen AG

B. Braun Melsungen AG is a leading manufacturer in the global syringes market, known for its innovative and safety-driven products. The company is a major player, contributing significantly to the market's growth, which is projected to reach $24.2 billion by 2030 with a CAGR of 6.9% from 2023 to 2030. B. Braun's products, such as the Original Perfusor Syringe and Omnifix syringes, are renowned for their consistent and dependable performance, and are free from harmful materials like BPA, DEHP, and PVC. The company's focus on safety and sterility, including the development of syringes with anti-removal caps, enhances patient safety and reduces the risk of needlestick injuries. B. Braun's strong market presence and commitment to innovation make it a key competitor in the syringes market. You can learn more about their products like the 5 ml Luer Lock Syringe on their website.

Cardinal Health

Cardinal Health is a prominent player in the syringes market, known for its high-quality medical products and extensive distribution network. The company serves over 100,000 locations and provides medical products to more than 75% of hospitals in the United States. Despite recent recalls of unauthorized plastic syringes made in China, such as those from Jiangsu Shenli Medical Production Co. Ltd, Cardinal Health remains committed to ensuring the safety and quality of its products. The company's syringe products are part of a larger market that is expected to grow significantly, with the U.S. syringes market projected to reach around USD 18.61 billion by 2034. Cardinal Health's dedication to quality and safety aligns with the increasing demand for reliable medical supplies. For more information on Cardinal Health's syringe products and surgical solutions, you can visit their website.

Medtronic

Medtronic is a leading manufacturer in the disposable syringes market, known for its innovative and safety-enhanced medical devices. The company, along with other major players like BD and Nipro Corporation, contributes significantly to the market's growth, which is anticipated to reach a CAGR of 6.2% from 2023 to 2030. In 2022, the global disposable syringes market was valued at USD 14.18 billion, with North America, where Medtronic has its operational headquarters, dominating the market with a 42% share. Medtronic's focus on technological advancements and the development of advanced products has helped the company gain substantial market shares. The increasing demand for safety syringes, which held a 65.2% market share in 2023, further solidifies Medtronic's position in the industry. For more information on Medtronic's innovative medical devices, visit their official website.

Henke-Sass, Wolf

Henke Sass Wolf is a leading OEM manufacturer in the medical technology sector, specializing in high-quality disposable syringes that ensure optimal application safety, functionality, and value for money. With decades of experience and continuous innovation, their products are used globally, particularly in veterinary, human, and dental applications. The company maintains production facilities worldwide, supporting their commitment to quality and innovation. Their disposable syringes are made from chemically stable materials, guaranteeing precise dosage and absolute tightness. The global disposable syringes market, in which Henke Sass Wolf is a key player, was estimated at USD 14.18 billion in 2022 and is expected to grow at a CAGR of 6.2% from 2023 to 2030.

McKesson Corporation

McKesson Corporation is a leading healthcare company that excels in the production and distribution of high-quality syringes, among other medical supplies. As a key player in the global syringes market, McKesson Medical-Surgical Inc. contributes significantly to the industry's growth, with the market expected to expand at a CAGR of ~7% from 2020 to 2030. McKesson's commitment to patient safety and quality assurance is evident in their response to FDA warnings, where they have stopped shipping certain plastic syringes to ensure compliance and safety. The company's diverse supplier network and continuous efforts to expand it further enhance their supply chain resiliency. McKesson's involvement in the syringes market is part of their broader mission to advance health outcomes for all.

EXELINT International

EXELINT International is a leading manufacturer and distributor of high-quality medical devices, including syringes and needles, with a strong reputation built over 40 years. The company obtained FDA 510k approval for its needles and syringes in 1986 and has since expanded its portfolio to include port access needles, infusion sets, and safety devices. EXELINT International has a global footprint, operating in 37 countries, and has achieved significant certifications such as ISO 13485 and MDSAP. The company's commitment to quality and innovation has made it a key player in the global syringe and needle market, which is expected to grow significantly due to increasing demand for safety syringes and rising chronic ailments.